Scripps Research has an impressive track record of identifying new drugs and biologics to improve health. Now we have embarked on a mission to link your personal genome and health measurements to your disease risk.

In the second lecture of the new Front Row Lecture Series, Professor Kristin Baldwin, PhD, aims to accelerate the personalization of drug discovery by turning genomic health discoveries into “disease in a dish” models. These models include what she calls “designer” cell types that mimic what is seen in diseases such as Alzheimer’s and Parkinson’s. Her work gives scientists new tools to rapidly identify therapeutic targets and screen promising drugs. In her Front Row Lecture, Baldwin provided an overview of this dynamic new approach to medicine and highlight recent discoveries from her lab.

Presented: September 13, 2018